Register for email alerts and news feeds:
This journal | BMJ Group
rss
Archives of Disease in Childhood 1999;81:329-332; doi:10.1136/adc.81.4.329
Copyright © 1999 BMJ Publishing Group Ltd & Royal College of Paediatrics and Child Health.
Arch Dis Child 1999;81:329-332 ( October )

Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years

Alessandra Cassio, Emanuele Cacciari, Antonio Balsamo, Milva Bal, Davide Tassinari

Department of Paediatrics, Bologna University, Via Massarenti 11, 40138 Bologna, Italy

Correspondence to: Professor Cacciari.

Accepted 4 June 1999

OBJECTIVE---To study the effectiveness of luteinising hormone releasing hormone (LHRH) analogues in improving final height in girls affected by early puberty.
PATIENTS---Forty six consecutive girls with onset of puberty aged 7.5-8.5 years randomly divided into two groups: one treated with 3.75 mg triptorelin intramuscularly every four weeks (group 1); and the other with no treatment (group 2).
RESULTS---Mean (SD) chronological age at onset of menarche was significantly higher in group 1 than in group 2 (11.9 (1.0) v 10.8 (0.7) years). However, mean (SD) height at menarche (152.7 (7.2) v 152.5 (5.7) cm) and mean (SD) growth after menarche (4.9 (3.0) v 5.4 (2.2) cm) were similar in both groups. The mean (SD) final height was similar in the two groups (group 1, 158.1 (6.2) cm; group 2, 158.6 (6.0) cm) and not significantly different from target height. Fourteen of 20 patients in group 1 and 12 of 18 patients in group 2 showed final height equal to or higher than target height. Final heights of girls with poor initial height prognosis were significantly lower than those of girls with good prognosis, but in patients with the same initial height prognosis, both groups showed final heights similar and not significantly different from their target heights.
CONCLUSIONS---LHRH analogue has no apparent effect on final height in subjects with onset of puberty between 7.5 and 8.5 years.


Keywords: early puberty; luteinising hormone releasing hormone analogue; final height; randomised trial


© 1999 by Archives of Disease in Childhood

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Carel, J.-C., Eugster, E. A., Rogol, A., Ghizzoni, L., Palmert, M. R., on behalf of the members of the ESPE-LWPES GnRH An, (2009). Consensus Statement on the Use of Gonadotropin-Releasing Hormone Analogs in Children. Pediatrics 123: e752-e762 [Abstract] [Full Text]  
  • Brito, V. N., Latronico, A. C., Cukier, P., Teles, M. G., Silveira, L. F. G., Arnhold, I. J. P., Mendonca, B. B. (2008). Factors Determining Normal Adult Height in Girls with Gonadotropin-Dependent Precocious Puberty Treated with Depot Gonadotropin-Releasing Hormone Analogs. J. Clin. Endocrinol. Metab. 93: 2662-2669 [Abstract] [Full Text]  
  • Lazar, L., Padoa, A., Phillip, M. (2007). Growth Pattern and Final Height after Cessation of Gonadotropin-Suppressive Therapy in Girls with Central Sexual Precocity. J. Clin. Endocrinol. Metab. 92: 3483-3489 [Abstract] [Full Text]  
  • Carel, J.-C., Lahlou, N., Roger, M., Chaussain, J. L. (2004). Precocious puberty and statural growth. Hum Reprod Update 10: 135-147 [Abstract] [Full Text]  
  • Lazar, L., Kauli, R., Pertzelan, A., Phillip, M. (2002). Gonadotropin-Suppressive Therapy in Girls with Early and Fast Puberty Affects the Pace of Puberty but Not Total Pubertal Growth or Final Height. J. Clin. Endocrinol. Metab. 87: 2090-2094 [Abstract] [Full Text]  
  • Lampit, M., Golander, A., Guttmann, H., Hochberg, Z.'e. (2002). Estrogen Mini-Dose Replacement during GnRH Agonist Therapy in Central Precocious Puberty: A Pilot Study. J. Clin. Endocrinol. Metab. 87: 687-690 [Abstract] [Full Text]  
  • Klein, K. O., Barnes, K. M., Jones, J. V., Feuillan, P. P., Cutler, G. B. Jr. (2001). Increased Final Height in Precocious Puberty after Long-Term Treatment with LHRH Agonists: The National Institutes of Health Experience. J. Clin. Endocrinol. Metab. 86: 4711-4716 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Latest from ADC

 

ADC is co-owned by the RCPCH and is the official journal of the European Academy of Paediatrics

BMJ Careers - Latest Paediatrics and Paediatric Surgery Jobs

Paediatrics and Paediatric Surgery Jobs